WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004031210) OPTIMIZED MULTI-EPITOPE CONSTRUCTS AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/031210    International Application No.:    PCT/US2003/031303
Publication Date: 15.04.2004 International Filing Date: 03.10.2003
Chapter 2 Demand Filed:    30.04.2004    
IPC:
A01N 63/00 (2006.01), A61K 31/7088 (2006.01), A61K 39/29 (2006.01), A61P 31/20 (2006.01), C07H 21/04 (2006.01), C07K 7/06 (2006.01), C07K 7/08 (2006.01), C07K 14/02 (2006.01), C12N 7/00 (2006.01), C12N 15/11 (2006.01), C12N 15/63 (2006.01)
Applicants: EPIMMUNE INC. [US/US]; 5820 Nancy Ridge Drive, San Diego, CA 92121 (US).
GENENCOR INTERNATIONAL, INC. [US/US]; 925 Page Mill Road, Palo Alto, CA 94304 (US)
Inventors: SETTE, Alessandro; (US).
CHESNUT, Robert; (US).
NEWMAN, Mark J.; (US).
LIVINGSTON, Brian D.; (US).
BABE, Lilia Maria; (US).
CHEN, Yiyou; (US).
DEYOUNG, Lawrence M.; (US).
HUANG, Manley T.F.; (US).
POWER, Scott D.; (US)
Agent: STEFFE, ERIC K.; Sterne, Kessler, Goldstein & Fox, P.L.L.C., 1100 New York Avenue, Washington, DC 20005 (US)
Priority Data:
60/415,463 03.10.2002 US
60/419,973 22.10.2002 US
Title (EN) OPTIMIZED MULTI-EPITOPE CONSTRUCTS AND USES THEREOF
(FR) CONSTRUCTIONS OPTIMISEES A PLUSIEURS EPITOPES ET UTILISATIONS DE CES DERNIERES
Abstract: front page image
(EN)The invention relates to the field of biology. In particular, it relates to multi-epitope nucleic acid and peptide vaccines and methods of designing such vaccines to provide increased immunogenicity.
(FR)La présente invention concerne le domaine de la biologie et se rapporte notamment à l'acide nucléique à plusieurs épitopes et aux vaccins peptidiques ainsi qu'à des méthodes de mise au point de tels vaccins pour accroître l'immunogénicité.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)